New guidelines for hypertrophic cardiomyopathy: the impact on prophylactic cardioverter-defibrillator implantation

被引：0
|
作者：
Godinho, A. R. [1 ]
Vasconcelos, M. [1 ]
Rangel, I. [1 ]
Araujo, V. [1 ]
Frutuoso, C. [1 ]
Cardoso, J. S. C. [1 ]
Maciel, M. J. [1 ]
机构：
[1] Univ Porto, Cardiol, P-4100 Oporto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1460
引用
收藏
页码：307 / 307
页数：1
相关论文
共 50 条
  • [41] Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Miyazawa, Kazuo
    Hayashi, Tomohiko
    Ito, Ryo
    Takahira, Haruhiro
    Kobayashi, Yoshio
    HEART AND VESSELS, 2021, 36 (01) : 99 - 104
  • [42] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Sinha, Anil-Martin
    Bense, Jens
    Hohenforst-Schmidt, Wolfgang
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 62 (02) : 401 - 407
  • [43] Survival after cardiac arrest in patients with hypertrophic cardiomyopathy: Role of the implantable cardioverter-defibrillator
    Borggrefe, MM
    McKenna, WJ
    CIRCULATION, 1999, 100 (18) : 76 - 76
  • [44] APPROPRIATE AND INAPPROPRIATE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: INCIDENCE AND PREDICTORS
    Min, David B.
    Masri, Ahmad
    Popovic, Zoran
    Kanj, Mohamed
    Smedira, Nicholas
    Lytle, Bruce
    Thamilarasan, Maran
    Lever, Harry
    Desai, Milind
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A319 - A319
  • [45] Reply to: Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Maurizi, Niccolo
    Olivotto, Iacopo
    Cecchi, Franco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 246 : 55 - 55
  • [46] Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy
    Gray, Belinda
    Ingles, Jodie
    Medi, Caroline
    Semsarian, Christopher
    JACC-HEART FAILURE, 2013, 1 (02) : 149 - 155
  • [47] Hypertrophic cardiomyopathy: Clinical risk stratification and cardioverter defibrillator implantation for primary prevention
    Anastasakis, A.
    Gatzoulis, K.
    Georgopoulos, S.
    Kotsiopoulou, C.
    Sevdalis, E.
    Ritsatos, K.
    Riga, M.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 57 - 57
  • [48] The Wearable Cardioverter-Defibrillator in Newly Diagnosed Cardiomyopathy
    Epstein, Andrew E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (23) : 2614 - 2617
  • [49] HYPERTROPHIC CARDIOMYOPATHY, CORONARY ECTASIA MYOCARDIAL BRIDGING & INTERNAL CARDIOVERTER DEFIBRILLATOR IMPLANTATION
    Ashraf, Tariq
    Shafquat, Azam
    Kundi, Asadullah
    PAKISTAN HEART JOURNAL, 2005, 38 (1-2): : 30 - 32
  • [50] Prophylactic Implantation of Implantable Cardioverter-Defibrillator for Japanese Patients With Heart Failure - Problem of "Underuse"
    Kuga, Keisuke
    CIRCULATION JOURNAL, 2015, 79 (02) : 297 - 299
12345